Overall rank by patents
#26,186
Across all tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 9 technology areas, active 2023–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
The verdict
EKO holds 10 US patents across 9 technology areas, rank #26,186 of 50,000 tracked assignees.
EKO Health, Inc. has been granted 10 US utility patents between 2023 and 2025, placing EKO Health, Inc. at rank #26,186 across all assignees tracked by PlainPatent. This portfolio spans 9 distinct Cooperative Patent Classification (CPC) subclasses, averaging 9.8 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, EKO Health, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, EKO sits between EHC Canada, Inc. (10 patents, rank #26,182) and Elantas PDG (10 patents, rank #26,190) - the closest US assignees by grant volume. The composite Innovation Score of 31.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2023 through 2025, with 10 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. EKO Health, Inc.'s 9.8 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 9 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark EKO Health, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
EHC CANADA, INC.
10 patents
EHS LENS PHILIPPINES, INC.
10 patents
EINNOVATIONS HOLDINGS PTE. LTD.
10 patents
EKC Technology, Inc.
10 patents
EKRA AUTOMATISIERUNGSSYSTEME GMBH
10 patents
EKWB d.o.o.
10 patents
ELANTAS GMBH
10 patents
ELANTAS PDG
10 patents
EKO HEALTH, INC.
10 patents
What this shows EKO holds 10 patents at rank #26,186, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
EKO's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
31 Top 62% higher than 38% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2023 | 1 | 10.0% |
| 2025 | 9 | 90.0% |
Top 9 of 9 technology areas
Overall rank by patents
#26,186
Across all tracked assignees
31.4 out of 100
How to use this portfolio
EKO's 10 grants land it in the top 62% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.